Neil Stahl, EVP Research and Development: Regeneron Pharmaceuticals REGN Sell · Filed 23/08/23

Trade details

Type: Insider sale
Amount: $5,302,903.77
Shares · price: 6,309 sh · $840.53 a share
Held after: 58,456 sh
Stock: Regeneron Pharmaceuticals REGN
Person: Neil StahlEVP Research and Development
Trade date: 23/08/22
Filed: 23/08/23
Days to filing: 1 days

Sold 9.7% of holdings

Share of holding sold: 9.7%

Regeneron Pharmaceuticals trades, last 26 weeks

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/07/23~23/09/21

Neil Stahl's recent trades

Neil StahlEVP Research and Development
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$2M
1,883 sh
$2M
Filed 24/08/12
Traded 24/08/08
Neil StahlEVP Research and Development
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$1.9M
1,708 sh
$1.9M
Filed 24/08/12
Traded 24/08/08
Neil StahlEVP Research and Development
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$1.1M
1,006 sh
$1.1M
Filed 24/08/12
Traded 24/08/08
Neil StahlEVP Research and Development
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$325.8K
300 sh
$325.8K
Filed 24/08/12
Traded 24/08/08
Neil StahlEVP Research and Development
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$216.5K
200 sh
$216.5K
Filed 24/08/12
Traded 24/08/08